Ownership Profile
Ownership Profile
Top Holders
| Holder | Shares Held | % O/S | Share Change | Filing Date |
|---|---|---|---|---|
| Fidelity Management & Research Company LLC | 21,172,154 | 14.99 | 27,699 | 9/30/21 |
| The Vanguard Group, Inc. | 11,800,009 | 8.36 | -855,820 | 9/30/21 |
| T. Rowe Price Associates, Inc. | 11,737,321 | 8.31 | -521,506 | 9/30/21 |
| Bellevue Asset Management AG | 9,347,926 | 6.62 | -582,319 | 9/30/21 |
| ARK Investment Management LLC | 8,511,384 | 6.03 | -396,349 | 9/30/21 |
| ClearBridge Investments, LLC | 7,327,322 | 5.19 | 511,721 | 9/30/21 |
| BlackRock Institutional Trust Company, N.A. | 6,648,842 | 4.71 | -240 | 9/30/21 |
| State Street Global Advisors (US) | 3,521,314 | 2.49 | 290,363 | 9/30/21 |
| Camber Capital Management LP | 2,500,000 | 1.77 | 500,000 | 9/30/21 |
| Geode Capital Management, L.L.C. | 1,772,767 | 1.26 | 10,227 | 9/30/21 |
Top Holders: Mutual Funds
| Fund | Shares Held | % O/S | Share Change | Filing Date |
|---|---|---|---|---|
| BB Biotech Fd | 9,112,973 | 6.45 | 946,011 | 9/30/21 |
| ARK Genomic Revolution ETF | 8,524,176 | 6.04 | 44,346 | 10/31/21 |
| Fidelity Growth Company Fund | 7,890,483 | 5.59 | -31,405 | 9/30/21 |
| T. Rowe Price Mid-Cap Growth Fund | 3,708,700 | 2.63 | -3,300 | 9/30/21 |
| Vanguard Total Stock Market Index Fund | 3,412,791 | 2.42 | 3,214 | 10/31/21 |
| Vanguard Small-Cap Index Fund | 2,997,632 | 2.12 | 11,694 | 10/31/21 |
| ClearBridge Aggressive Growth Fund | 2,086,537 | 1.48 | -220,254 | 9/30/21 |
| Vanguard Extended Market Index Fund | 1,897,599 | 1.34 | 3,430 | 10/31/21 |
| Vanguard Small-Cap Growth Index Fund | 1,884,323 | 1.33 | -1,570 | 10/31/21 |
| First Trust NYSE Arca Biotechnology Index Fund | 1,697,209 | 1.20 | 36,910 | 10/31/21 |
* Insider values reflect direct beneficial ownership.
Copyright Refinitiv